Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112898202B discloses a mild photocatalytic route to heterocyclic cyclopropanes. This technology offers cost reduction in pharmaceutical intermediate manufacturing through scalable, visible-light catalysis.
Patent CN117088826B enables visible light synthesis of oxazoles. Offers green chemistry solutions for reliable pharmaceutical intermediates supplier partners seeking cost reduction.
Novel visible light photocatalysis method for C2-difluoroalkylbenzimidazole derivatives offers mild conditions and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN105669522B reveals metal-free visible light synthesis for high-purity indolinones offering substantial cost reduction and supply chain reliability for global pharmaceutical manufacturing.
Novel visible-light catalyzed method for 3-alkyl quinoxalin-2(1H)-ones. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Novel visible-light driven Ru-catalyst enables room-temp alkyne-aldehyde addition. Reduces energy costs and simplifies supply chain for API synthesis.
Patent CN117304094A reveals visible-light method for high-purity 3-trifluoromethylpyridine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel patent CN114573512B enables mild visible light synthesis. Reduces toxicity and cost for pharmaceutical intermediates manufacturing supply chain.
Patent CN114874139A details a green visible-light method for 1-benzyl-3,4-dihydroisoquinoline. Offers cost-effective, scalable pharma intermediate production.
Patent CN110540516B reveals a mild visible-light mediated synthesis for dihydronaphthalene derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN105669546A enables efficient photocatalytic synthesis. Delivers high-purity fluorinated building blocks with significant supply chain and cost advantages for global pharmaceutical manufacturing.
Patent CN110305054B details a green FeBr3-catalyzed route for N-(1-phenyl-2-(phenylseleno)ethyl)aniline derivatives, offering cost reduction and scalable manufacturing.
Patent CN114560832A reveals a green two-step route to dibenzofurans using visible light and palladium catalysis, offering cost-effective manufacturing solutions.
Novel Ru-catalyzed blue light method for 1,2,3-triazole quinoxalinones. High yield, mild conditions, reliable pharmaceutical intermediate supply chain solution.
Novel radical amino migration patent enables mild benzolactam synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN112047839B reveals a visible-light driven method for high-purity 1-iodo-3-perfluoroalkyl alkenes. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN115232159A reveals a novel photoredox C-H borylation method. Enables cost reduction in pharmaceutical intermediate manufacturing with high regioselectivity.
Patent CN112028841A reveals a catalyst-free visible light method for high-yield quinoxalinone synthesis, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114805209A details a metal-free photocatalytic route for 3-aryl-2H-indazoles using aryl sulfonium salts, offering cost reduction and supply chain reliability.
Patent CN111777564B details a green aqueous photocatalytic method for quinazolinones using KI, offering cost-effective and scalable production for pharmaceutical intermediates.